United States · FDA National Drug Code directory
Terconazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-717_006c6bda-594f-46ce-ba64-d075022ed4b4
- Product NDC
- 45802-717
- Form
- SUPPOSITORY
- Composition / generic term
- Terconazole
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060828
- Source listing expiry
- 20271231
Source-listed ingredients
- TERCONAZOLE — 80 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (45802-717-08) / 1 SUPPOSITORY in 1 BLISTER PACK (45802-717-00) · 45802-717-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →